PRESS RELEASES




  1. Actamax Receives Approval to Begin Pivotal Clinical Trial for Actamax™ Adhesion Barrier

    September 20, 2017



  2. Actamax™ submits IDE to FDA for pivotal study on novel Sprayable Adhesion Barrier Device

    February 21, 2017



  3. Actamax announces presentation on 12 months clinical follow-up outcomes of novel sprayable adhesion barrier device

    November 14, 2016



  4. Actamax Announces Positive Results from First Clinical Trial Demonstrating Safety, Ease of use and Efficacy of Novel Sprayable Adhesion Barrier Device

    November 10, 2014



  5. DSM and DuPont announce joint venture in surgical biomedical materials

    September 23, 2010